BridgeMD
New treatment option for Optical Phenomena
Official title Attention Modulation of Local and Global Inhibition Mechanisms
ClinicalTrials.gov ID: NCT04279158
What this study is testing
- What it's testing
- Human behavior is both flexible and adapted to the environmental context through inhibition capabilities; the investigator control the subject's behavior by repressing inappropriate responses and selecting, among several possibilities, those that are appropriate. These mechanisms are not independent of attentional control.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 75. Healthy volunteers may be eligible.
You may be able to join if
- All patients and healthy people:
- male and female, age from 18 to 75 years included
- normal vision or corrected vision
- covered by social security
- signed written informed consent
You likely can't join if
- unable to comply with requirements of the study (neurological, psychiatric, sensory or motor troubles)
- adults under legal protection Patient with hemispatial neglect: Inclusion Criteria:
- After a stroke (\> 1 month ago), presence of a neurological impairment documented by brain imaging (standard of care) and by clinical symptoms.
- The diagnosis will be dissociated from hemianopia by perimetry. The hemispatial neglect consists of a lack of perception and responsiveness...
- After a stroke (\> 1 month ago), presence of neurological injury in parietal cortex only, supported by a standard of care cerebral MRI
- Present optic ataxia symptoms (The OA consists of pointing errors with the hand contralateral to the lesion (hand effect) and / or to visual targets...
See the full eligibility criteria
- All patients and healthy people:
- male and female, age from 18 to 75 years included
- normal vision or corrected vision
- covered by social security
- signed written informed consent
- unable to comply with requirements of the study (neurological, psychiatric, sensory or motor troubles)
- adults under legal protection Patient with hemispatial neglect: Inclusion Criteria:
- After a stroke (\> 1 month ago), presence of a neurological impairment documented by brain imaging (standard of care) and by clinical symptoms.
- The diagnosis will be dissociated from hemianopia by perimetry. The hemispatial neglect consists of a lack of perception and responsiveness concerning the controlesional visual hemifield. Patient with optic ataxia:
- After a stroke (\> 1 month ago), presence of neurological injury in parietal cortex only, supported by a standard of care cerebral MRI
- Present optic ataxia symptoms (The OA consists of pointing errors with the hand contralateral to the lesion (hand effect) and / or to visual targets presented in the field contralateral to the lesion (field effect))...
- present a diagnosis of ADHD subtype inattention or impulse / hyperactivity as established by a neuropsychologist.
- Children will be between 8 and 18 years old
- Adults will be between 18 and 75 years old.
- Participants will not report any comorbid learning disabilities to ADHD. For minors: \- Having obtained the written consent of the legal representative(s) Healthy people Inclusion Criteria: \- no known neurological...
The study team makes the final eligibility decision.
Where it's taking place
- Bron, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 75 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bron, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.